Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Bionx Implants, Inc. (NasdaqNM:BINX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Recent Events
July 31Price hit new 52-week high ($3.54)
Location
1777 Sentry Parkway West
Gwynedd Hall, Suite 400
Blue Bell, PA 19422
Phone: (215) 643-5000
Fax: (215) 653-6128
Employees (last reported count): 132
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 63%
·Institutional: 24% (64% of float)
(17 institutions)
·Net Inst. Buying: 864.0K shares (+25.21%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Bionx Implants, Inc. is a developer, manufacturer and marketer of self-reinforced, resorbable polymer implants, including screws, pins, arrows and stents, for use in a variety of applications, including sports medicine, orthopedic trauma and craniofacial surgery and urology. The Company has proprietary manufacturing processes for self-reinforced resorbable polymers, modifying the brittle polymer structure into a physiologically strong structure with controlled, variable-strength retention. During 2000, the Company released the 4.5 mm resorbable Cannulated Screw for the maintenance of alignment of cancellous bone fractures of the malleolus of the ankle as the intended first in a line of cannulated products. The cannulation enables the surgeon to place a guide wire at the fracture or osteotomy site in order to obtain initial reduction and then insert the screw over the wire for final fixation.
More from Market Guide: Expanded Business Description

Financial Summary
BINX is a developer, manufacturer and marketer of Self-Reinforced, resorbable polymer implants for use in a variety of applications which include orthopaedic surgery, urology, dentistry and maxillo-facial surgery. For the three months ended 3/31/01, total revenues decreased 2% to $5 million. Net loss increased 51% to $568 thousand. Results reflect temporary dislocations and inefficiencies as the Company reorganized its distribution network.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 4,842; after tax earnings were -1,120. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

Terry Wall, 58
Chairman
--  
Gerard Carlozzi, 43
Pres, CEO, Director
$152K
Pertti Tormala, Ph.D., 54
Exec. VP- Research and Developmant
131K
Drew Karazin, 46
VP, CFO
--  
Gregory Jones, 41
VP- Marketing
156K
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:BINXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 26-Dec-2000
$0.688
Recent Price$3.50 
52-Week High
on 31-July-2001
$3.54 
Beta1.44 
Daily Volume (3-month avg)20.7K
Daily Volume (10-day avg)97.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change+24.4%
52-Week Change
relative to S&P500
+66.9%
Share-Related Items
Market Capitalization$37.9M
Shares Outstanding10.8M
Float4.00M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$1.57 
Earnings (ttm)-$0.47 
Earnings (mrq)-$0.10 
Sales (ttm)$1.70 
Cash (mrq*)$0.54 
Valuation Ratios
Price/Book (mrq*)2.23 
Price/EarningsN/A 
Price/Sales (ttm)2.06 
Income Statements
Sales (ttm)$18.5M
EBITDA (ttm*)-$2.89M
Income available to common (ttm)-$5.14M
Profitability
Profit Margin (ttm)-27.7%
Operating Margin (ttm)-25.8%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-22.32%
Return on Equity (ttm)-27.25%
Financial Strength
Current Ratio (mrq*)4.52 
Debt/Equity (mrq*)0.02 
Total Cash (mrq)$5.23M
Short Interest
As of 8-Aug-2001
Shares Short0 
Shares Short
(Prior Month)
5,000 
Daily Volume5,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.